Community-based noncommunicable disease interventions ...
Community-based noncommunicable disease interventions: lessons from developed countries for developing ones Aulikki Nissinen,1 Ximena Berrios,2 & Pekka Puska3 Community-based programmes for prevention and control of cardiovascular diseases (CVD) started in Europe and
Download Community-based noncommunicable disease interventions ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Global report on PSORIASIS - WHO
apps.who.intGlobal report on psoriasis 1 Foreword Psoriasis is a common, chronic, noncommunicable skin disease, with no clear cause or cure. The negative impact …
Noncommunicable diseases (brochure) - WHO/Europe
www.euro.who.intThe epidemic of noncommunicable diseases (NCDs) is the epidemic of the 21st century. Within the WHO European Region, the impact of the major noncommunicable diseases
PHILIPPINES 2016 TOTAL POPULATION: 2016 TOTAL DEATHS ...
www.who.intphilippines risk of premature death due to ncds (%) selected adult risk factor trends proportional mortality probability (%) of premature death national target set data year males females total
The Global Economic Burden of Non-communicable Diseases
www3.weforum.orgAug 25, 2011 · The Global Economic Burden of Non-communicable Diseases A report by the World Economic Forum and the Harvard School of Public Health September 2011